|  Help  |  About  |  Contact Us

Publication : Differential Role of the RAC1-Binding Proteins FAM49b (CYRI-B) and CYFIP1 in Platelets.

First Author  Sisario D Year  2024
Journal  Cells Volume  13
Issue  4 PubMed ID  38391912
Mgi Jnum  J:345628 Mgi Id  MGI:7608666
Doi  10.3390/cells13040299 Citation  Sisario D, et al. (2024) Differential Role of the RAC1-Binding Proteins FAM49b (CYRI-B) and CYFIP1 in Platelets. Cells 13(4)
abstractText  Platelet function at vascular injury sites is tightly regulated through the actin cytoskeleton. The Wiskott-Aldrich syndrome protein-family verprolin-homologous protein (WAVE)-regulatory complex (WRC) activates lamellipodia formation via ARP2/3, initiated by GTP-bound RAC1 interacting with the WRC subunit CYFIP1. The protein FAM49b (Family of Unknown Function 49b), also known as CYRI-B (CYFIP-Related RAC Interactor B), has been found to interact with activated RAC1, leading to the negative regulation of the WRC in mammalian cells. To investigate the role of FAM49b in platelet function, we studied platelet-specific Fam49b(-/-)-, Cyfip1(-/-)-, and Cyfip1/Fam49b(-/-)-mice. Platelet counts and activation of Fam49b(-/-) mice were comparable to those of control mice. On fully fibrinogen-coated surfaces, Fam49b(-/-)-platelets spread faster with an increased mean projected cell area than control platelets, whereas Cyfip1/Fam49b(-/-)-platelets did not form lamellipodia, phenocopying the Cyfip1(-/-)-platelets. However, Fam49b(-/-)-platelets often assumed a polarized shape and were more prone to migrate on fibrinogen-coated surfaces. On 2D structured micropatterns, however, Fam49b(-/-)-platelets displayed reduced spreading, whereas spreading of Cyfip1(-/-)- and Cyfip1/Fam49b(-/-)-platelets was enhanced. In summary, FAM49b contributes to the regulation of morphology and migration of spread platelets, but to exert its inhibitory effect on actin polymerization, the functional WAVE complex must be present.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

13 Bio Entities

Trail: Publication

0 Expression